Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

12.34
Delayed Data
As of 4:02pm ET
 -0.85 / -6.44%
Today’s Change
10.26
Today|||52-Week Range
29.11
-48.73%
Year-to-Date

Today’s Trading

Previous close13.19
Today’s open13.20
Day’s range12.20 - 13.34
Volume1,395,346
Average volume (3 months)1,249,755
Market cap$1.6B
Data as of 4:02pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-107.89%
Earnings growth (this year)+32.28%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales15.02
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-6.83-8.31%
HALOHalozyme Therapeutic...-0.26-1.25%
AVXSAveXis Inc+0.60+0.61%
ONCESpark Therapeutics I...-0.70-1.52%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$190.9M
Annual profit (last year)-$186.6M
Net profit margin-97.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Thomas Bostick
Corporate headquarters
Germantown, Maryland

Forecasts